Traduction de «disease level » (Anglais → Français) :

attack rate [ AR | disease rate | disease level ]

infectious disease [ bacterial disease | cholera | communicable disease | contagious disease | leprosy | malaria | parasitic disease | sleeping sickness | trypanosomiasis | tuberculosis | viral disease | viral diseases | yellow fever ]

illness [ disease | human disease(GEMET) ]

blue disease | blue ear disease | blue-ear disease of pigs | mysterious pig disease | mysterious swine disease | mystery pig disease | new pig disease | porcine epidemical abortion | porcine reproductive and respiratory syndrome | purple ears disease | MSD [Abbr.] | PRRS [Abbr.]

Basedow's disease | exophthalmic goiter | Flajani's disease | Graves disease | Graves's disease | March's disease | Parry disease | Parry's disease | Stokes's disease | thyrotoxicosis

disease vector [ disease carrier | disease-carrying insect | vector of human diseases(GEMET) | vector-borne diseases(UNBIS) ]

bloat of onion | Brown ring disease of hyacinth | bulb eelworm | clover sickness | onion bloat | ring disease of bulbs | segging of oats | stem and bulb eelworm | stem and bulb nema | stem and bulb nematode disease | stem disease of clover and alfalfa | stem disease of rye | stem eelworm | stem nematode | tulip-root of oats

describe the molecular basis of a disease to a patient | explain the metabolic basis of a disease to a patient | explain molecular basis of diseases to patients | explain the molecular basis of a disease to patients

automatic leveling system [ ride height control | automatic ride control | load-levelling system | height compensator | self-levelling system | self levelling suspension | electronic levelling system | automatic leveling suspension | ground clearance compensator | electronic levelling control | self-le ]

Graves' disease [ Graves disease | Basedow's disease | Basedow disease | von Basedow disease | Basedow's syndrome | exophthalmic goiter | diffuse toxic goiter | struma exophthalmica | Flajani's disease | Flajani-Basedow syndrome | Parry's disease | Marsh's disease | Begbie's disease ]

(Return tabled) Question No. 469 Ms. Kirsty Duncan: With regard to maternal, newborn, and child health (MNCH): (a) in the answer provided to written question Q-208, (i) what services, key health and nutrition interventions are included in “scale-up integrated productive, maternal, newborn, and child health services”, (ii) what specific services and interventions are included in “family planning services”, (iii) what are the specific “commodities” referenced, (iv) what does “we are prepared to do more” mean, (v) what diplomatic and financial efforts has the government made or is considering, “to do more”, and in what Canadian and global forums, beyond the announced summit Canada will host on MNCH in Toronto at the end of May; (b) what consi ...[+++]deration has the government given to a signature Canadian contribution to the post-2015 development agenda; (c) what consideration and diplomatic efforts has the government made or is it considering, and in what forums, to support the inclusion of a specific high-level goal in the post-2015 agenda to improve health and nutrition outcomes for women, newborns, and children; (d) what financial efforts has the government made or is it considering, and in what forums, to improve the health outcomes for (i) women, (ii) newborns, (iii) children, broken down by initiative; (e) regarding the Muskoka Initiative, what consideration and diplomatic and financial efforts, and in what forums, has the government given to (i) recommit to the investments made, (ii) extend and increase this Initiative or a similar one, beyond 2015 and beyond the $2.85 billion envelope, (iii) targeting the efforts of this Initiative to more effectively reach and provide health care to the most vulnerable mothers, newborns, and children, (iv) recommit to the vaccine investments made in this Initiative and to extend and increase the commitments made; (f) what diplomatic and financial efforts has the government made, or is it considering, and in what forums, to incr ...

Maintain the EU’s coordinative role in the development of the EU policy on rare diseases and to support Member States in their activities on the national level. Continue to support the development of high quality National Rare Diseases Plans/Strategies in the European Union. Provide continued support for the International Rare Disease Research Consortium and initiatives developed under its umbrella. Continue to ensure proper codification of rare diseases. Work further to decrease inequalities between patients with rare diseases and pa ...[+++]tients suffering from more common disorders and to support initiatives promoting equal access to diagnosis and treatment. Continue to promote patients empowerment in all aspects of rare diseases policy development Continue activities increasing public awareness about rare diseases and EU activity in this field Make use of the Directive 2011/24/EU on the application of patients’ rights in cross-border healthcare to bring together European Reference Networks on rare diseases. Support the development of the tools facilitating cooperation and interoperability of the European Reference Networks for rare diseases. Stimulate development and use of eHealth solutions in the area of rare diseases. Implement and continue support for the European Platform on rare diseases registration. Continue playing a global role in the rare diseases initiative and collaborating with important international stakeholders.

(36) Based on the importance and the level of impact of a listed disease, its distribution, prevalence and incidence in the Union and the availability of disease prevention and control measures in respect of that listed disease, a different category of specific disease prevention and control rules provided for in this Regulation should apply coherently and consistently to each listed disease.

(Return tabled) Question No. 141 Ms. Kirsty Duncan: With respect to climate change and international and national security: (a) what does the government project are the potential impacts on currently stable regions of the world of such climate change-related phenomena as, but not limited to, (i) rises in sea level, (ii) increases in extreme weather events, (iii) increases in the spread of infectious disease, (iv) increases in environmental refugees; (b) what does the government project will be (i) the consequences of the impacts iden ...[+++]tified in (a)(ii), (a)(iii), and (a)(iv) on domestic military missions, (ii) the consequences of (a)(i), (a)(ii), (a)(iii), (a)(iv) and (b)(i) in terms of the military’s capacity to respond and the availability of troops for missions not related to conflicts induced by climate change-related phenomena; (c) what does the government project will be the potential impacts on already-weakened states of such climate change-related phenomena as, but not limited to, (i) sea level rise, (ii) extreme weather events, (iii) the spread of infectious diseases; (d) what does the government project will be the extent of the effects climate impacts could have on already-weakened states, including, but not limited to, (i) expanded ungoverned spaces, (ii) further weakened and failed states, (iii) increased conflicts, (iv) increased migrations; (e) what does the government project will be the impact of the effects identified in (d) on Canada’s national security; (f) which nations does the government project will be most affected by climate change, (i) what is the government’s assessment of each such country’s capacity to adapt or cope, (ii) what, if any, action is Canada taking to strengthen the capacity of weak governments to better cope with societal needs projected to arise as a result of climate change-related impacts, (iii) what is the government’s assessment of possible security risks if Canada does contribute to international efforts related to ...